In silico site of metabolism prediction of cytochrome P450-mediated biotransformations

By Tarcsay ÁÁkos   Keserűű Gyöörgy M  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 3, 2011-03 ,pp. : 299-312

Informa Healthcare

Access to resources Recommend Favorite

Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling

By Dong Dong   Wu Baojian  

Drug Metabolism Reviews, Vol. 44, Iss. 1, 2012-02 ,pp. : 1-17

Informa Healthcare

Access to resources Recommend Favorite

Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling

By Dong Dong   Wu Baojian   Chow Diana   Hu Ming  

Drug Metabolism Reviews, Vol. 44, Iss. 2, 2012-05 ,pp. : 192-208

Informa Healthcare

Access to resources Recommend Favorite

High-throughput and in silico screenings in drug discovery

By Phatak Sharangdhar S   Stephan Clifford C   Cavasotto Claudio N  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 9, 2009-09 ,pp. : 947-959

Informa Healthcare

Access to resources Recommend Favorite

In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug Interactions

By Karlgren Maria   Ahlin Gustav   Bergström Christel   Svensson Richard   Palm Johan   Artursson Per  

Pharmaceutical Research, Vol. 29, Iss. 2, 2012-02 ,pp. : 411-426

Springer Publishing Company

Access to resources Recommend Favorite